15 results
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
fiscal year 2023.
Executive Compensation
The following table sets forth all compensation paid to our named executive officers at the end of the fiscal … shall:
Establish, review, and approve the overall executive compensation philosophy and policies of the Company, including the establishment
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
of these filings, we believe that all required Section 16(a) fillings were made on a timely basis during fiscal year 2023.
Executive Compensation … shall:
Establish, review, and approve the overall executive compensation philosophy and policies of the Company, including the establishment
424B4
BGLC
BioNexus Gene Lab Corp
21 Jul 23
Prospectus supplement with pricing info
3:37pm
and Analysis of Financial Condition and Results of Operations
Business
Regulation
Management
Executive Compensation
Principal Shareholders
Related Party … executive compensation in our periodic reports and proxy statements and the exemptions from the requirements of holding a nonbinding advisory vote
10-K
1y3oynj
31 Mar 20
Annual report
1:12pm
S-1/A
8wtypa69wm74peujrnh
25 Feb 19
IPO registration (amended)
3:30pm
UPLOAD
m3ajwyz
19 Feb 19
Letter from SEC
12:00am
S-1
ll1vpn
29 Jan 19
IPO registration
12:00am
- Prev
- 1
- Next